Quantexa is exploring a multibillion-dollar initial public offering in either the United Kingdom or the United States [1].
The decision represents a significant test for the London Stock Exchange as it competes with U.S. markets to attract high-growth technology firms. A listing in the U.S. often provides access to deeper capital pools, while a UK listing would keep the AI firm anchored in its home market.
Quantexa specializes in artificial intelligence and data analytics. The company aims to tap larger capital markets to fund the further growth of its data-analytics platform [1].
CEO Vishal Marria said the company is considering both options to determine which environment is most conducive to its goals. "We are exploring both a UK and a US listing to see which market best supports our growth ambitions," Marria said [2].
While the company has signaled its readiness for the public market, the exact date for the filing remains unconfirmed. Marria said the firm is "IPO-ready but still deciding on timing" [2].
The potential IPO is expected to carry a multibillion-dollar valuation [1]. This scale would place Quantexa among the most prominent AI-driven data firms emerging from the British tech sector.
Market analysts are watching the move closely to see if the company chooses the New York Stock Exchange or NASDAQ over the London Stock Exchange. The choice will likely depend on the valuation premiums offered by U.S. investors compared to those in the UK.
“We are IPO-ready but still deciding on timing.”
Quantexa's hesitation between London and New York reflects a broader trend of 'listing drift,' where European unicorns seek U.S. exchanges for higher valuations and greater liquidity. If Quantexa chooses a U.S. listing, it may signal continued weakness in the UK's ability to retain its most successful tech companies during their most critical growth phases.
